Megan Garlapow, PhD

Pomalidomide, cyclophosphamide, and dexamethasone triplet therapy for relapsed/refractory multiple myeloma had an overall response rate of 76%.

Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.

Researchers argue that palliative care integration into treatment regimens contribute to improving the quality of life for patients in phase 1 clinical trials.

A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.

This approach to managing opioid misuse/diversion and addiction in oncology patients stresses use harm reduction, instead of an attempt at abstinence or addiction treatment.

Tobacco-cessation program at an ambulatory cancer center sought to reduce smoking among patients undergoing treatment for cancer.

Novel innovations enhanced nurse education on pain assessment a re-assessment that enhanced patient satisfaction, although documentation still lagged at the end of the project.

An analysis of SEER data identified the risk for these cardiovascular events and the common related causes of death among patients with MM.

Researchers review the myMPN patient registry and provide an analysis of the data being collected by the registry, as well as future goals.

Prospective, longitudinal study sought to determine the risk factors for developing pain in women with breast cancer undergoing adjuvant radiotherapy.